FDA Announces Discontinuation Of Manufacture Of DYMISTA Nasal Spray, 137 mcg; 50 mcg A Registered Trademark Of Meda Pharmaceuticals Inc., A Viatris Company

Benzinga · 09/04/2025 15:37